AhR–ROR-γt Complex Is a Therapeutic Target for MAP4K3/GLKhighIL-17Ahigh Subpopulation of Systemic Lupus Erythematosus

FASEB Journal - United States
doi 10.1096/fj.201900105rr
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Treat-To-Target in Systemic Lupus Erythematosus: The Time Is Now!

Egyptian Journal of Rheumatology and Clinical Immunology
2015English

Therapeutic Inhibition of Proteasomes in Systemic Lupus Erythematosus

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2011English

Is Low Disease Activity Good Enough as a Target in Systemic Lupus Erythematosus?

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

To Target or Not to Target APRIL in Systemic Lupus Erythematosus: That Is the Question!

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2013English

Dickkopf-1 Is a Biomarker for Systemic Lupus Erythematosus and Active Lupus Nephritis

Journal of Immunology Research
MedicineAllergyImmunology
2017English

Systemic Lupus Erythematosus

JAMA - Journal of the American Medical Association
Medicine
2011English

Extracellular Vesicles as Therapeutic Agents in Systemic Lupus Erythematosus

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2017English

Systemic Lupus Erythematosus

Deutsche Medizinische Wochenschrift
Medicine
2005English

Systemic Lupus Erythematosus

Clinical and Developmental Immunology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy